Psyber, an atai Life Sciences company, is a globally-based startup focused on the development of brain-computer interface-enabled (BCI) digital therapeutics for treating mental health issues. By combining the growing potential of BCI-enabled digital therapeutics with psychedelics, Psyber aims to improve psychotherapy to all those who need it — wherever and whenever they need it.
